Market Overview

The Global Liver Cancer Therapeutics Market was valued at USD 3,274.5 million in 2023 and is expected to reach USD 15,860.6 million by 2031 while growing at a CAGR of 21.8% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global liver cancer therapeutics market growth. The primary treatments for liver cancer typically involve tumor ablation and direct chemotherapy administration for primary liver cancer, while chemotherapy or a combination of surgery and chemotherapy are commonly utilized for secondary liver cancer.

The growth of the market is propelled by the rising incidence of liver cancer, the expanding geriatric population, and heightened awareness leading to early detection. Conversely, the market is impeded by the high cost and adverse effects of treatment.

Furthermore, the global liver cancer therapeutics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Therapy Type Analysis

The Global Liver Cancer Therapeutics Market is segmented among Targeted Drug Therapy, Immunotherapy, and Chemotherapy, based on Therapy Type. In 2023, Targeted Drug Therapy accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Distribution Channel Analysis

The Global Liver Cancer Therapeutics Market is segmented among Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, based on Distribution Channel. In 2023, Hospital Pharmacies accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Liver Cancer Therapeutics Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Bayer Healthcare Pharmaceuticals Inc., Bristol-Myers & Squibb Company, Pfizer Inc., Exelixis Inc, Eisai Inc., Eli Lily and Company, F. Hoffmann La Roche Ltd.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Liver Cancer Therapeutics Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Liver Cancer Therapeutics Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Liver Cancer Therapeutics Market Segmentation, By Therapy Type

• Global Liver Cancer Therapeutics Market Share Analysis, By Therapy Type

• Global Liver Cancer Therapeutics Market Growth Analysis, By Therapy Type

• Global Liver Cancer Therapeutics Market Trends, By Therapy Type

o Targeted Drug Therapy

o Immunotherapy

o Chemotherapy

6. Global Liver Cancer Therapeutics Market Segmentation, By Distribution Channel

• Global Liver Cancer Therapeutics Market Share Analysis, By Distribution Channel

• Global Liver Cancer Therapeutics Market Growth Analysis, By Distribution Channel

• Global Liver Cancer Therapeutics Market Trends, By Distribution Channel

o Hospital Pharmacies

o Retail Pharmacies

o Online Pharmacies

7. Global Liver Cancer Therapeutics Market Segmentation, By Region

• Global Liver Cancer Therapeutics Market Share Analysis, By Region

• Global Liver Cancer Therapeutics Market Growth Analysis, By Region

• Global Liver Cancer Therapeutics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Bayer Healthcare Pharmaceuticals Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Bristol-Myers & Squibb Company

• Pfizer Inc.

• Exelixis Inc

• Eisai Inc.

• Eli Lily and Comapny

• F. Hoffmann La Roche Ltd

*Similar analysis will be provided for each company listed above.